Mar 22
Irresistible Change: How to Spot Real Growth
How can investors tell the difference between a real value-creating transformation and “compliance theatre”? Phil Gilbert, serial entrepreneur and former IBM General Manager, joins the show to talk about his new book, Irresistible Change: A Blueprint for Earning Buy-In and Breako ... Show More
19m 59s
Mar 21
The Best Places to Retire, and Play It Safer Before Retirement
The No. 1 investing goal of most Americans is retirement, and a key determinant of happiness in retirement is where you live. Which factors are most important, and where are the places that have those factors? Robert Brokamp and Matt Frankel discuss The Motley Fool’s recent “Best ... Show More
23m 15s
Jun 2016
Bloomberg Surveillance: Bloomberg BNA's Eleanor Tyler on pharma
Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ... Show More
6m 38s
Mar 2023
#661: Dr. Peter Attia — The Science and Art of Longevity, Optimizing Protein, Alcohol Rules, Lessons from Glucose Monitoring with CGMs, Boosting Your VO2 Max, Preventing Alzheimer's Disease, Early Cancer Detection, How to Use DEXA Scans, Nature’s Longevity Drug, and More
2h 22m
Mar 2023
Antibiotics: How to fix a broken market
Antibiotics stopped providing big gains for pharmaceutical companies decades ago, but as bacteria become more resistant to drugs, the world needs new classes of antibiotics to be discovered if we want to prevent the next global health crisis.Dr Tina Joshi, Associate Professor of ... Show More
18m 23s
Nov 2022
#633: Chris Palmer, MD, of Harvard Medical School — Optimizing Brain Energy for Mental Health, The Incredible Potential of Metabolic Psychiatry, Extraordinary Case Studies, and Harnessing Mitochondria for Anxiety, Depression, OCD, PTSD, and More
1h 59m
Jun 2021
Moderna: The Software of Life - [Business Breakdowns, EP. 13]
Today, we will be diving into Moderna. Founded in 2010, Moderna and its innovative RNA platform made headlines after developing one of the first COVID vaccines. We treated this Breakdown slightly different than our other episodes. I’m joined today by two guests. First, I am joine ... Show More
1h 9m
Weight loss drugs are taking center spotlight, but other developing treatments could change how we live. Deidre Woollard caught up with Motley Fool biotech analyst Karl Thiel to discuss:
- Biogen’s next shot at an Alzheimer’s treatment.
- Why companies can’t “muscle their way” into making new molecules.
- How NVIDIA could change drug development.
- Moderna ... Show More
<p><strong><em>Brought to you by </em></strong><a href="http://wealthfront.com/tim" rel="noopener noreferrer" target="_blank"><strong><em>Wealthfront</em></strong></a><strong><em> high-yield savings account, </em></strong><a href="http://helixsleep.com/tim" rel="noopene ... Show More
<p><strong><em>Brought to you by </em></strong><a href="http://levels.link/tim" rel="noopener noreferrer" target="_blank"><strong><em>Levels</em></strong></a><strong><em> real-time feedback on how diet impacts your health, </em></strong><a href="http://athleticgreens.co ... Show More
